#### 7.8.4.3 CTI-3 Study Scheduled Time Point (CWE) 01055

Components: &lt;Identifier (ST)> ^ &lt;Text (ST)> ^ &lt;Name of Coding System (ID)> ^ &lt;Alternate Identifier (ST)> ^ &lt;Alternate Text (ST)> ^ &lt;Name of Alternate Coding System (ID)> ^ &lt;Coding System Version ID (ST)> ^ &lt;Alternate Coding System Version ID (ST)> ^ &lt;Original Text (ST)> ^ &lt;Second Alternate Identifier (ST)> ^ &lt;Second Alternate Text (ST)> ^ &lt;Name of Second Alternate Coding System (ID)> ^ &lt;Second Alternate Coding System Version ID (ST)> ^ &lt;Coding System OID (ST)> ^ &lt;Value Set OID (ST)> ^ &lt;Value Set Version ID (DTM)> ^ &lt;Alternate Coding System OID (ST)> ^ &lt;Alternate Value Set OID (ST)> ^ &lt;Alternate Value Set Version ID (DTM)> ^ &lt;Second Alternate Coding System OID (ST)> ^ &lt;Second Alternate Value Set OID (ST)> ^ &lt;Second Alternate Value Set Version ID (DTM)>

Definition: This field identifies a time point in the clinical trial phase. _CTI-2 Study Phase Identifier_ must be valued if _CTI-3 Study Scheduled Time Point_ is valued. Should correspond to _CSS-1 Study Scheduled Time Point_. Refer to Table 0598 - Study Scheduled Time Point in Chapter 2C for valid values.
